Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CURRICULUM VITAE FRANK A. BUCCI, JR., M.D. 166 West Mt. Airy Road Shavertown, PA 18708 1970 - 1974 Rollins College, Winter Park, Florida B.A. Economics - Full Basketball Scholarship 1974 - 1976 Account Executive, Construction Materials Division, Lehigh Portland Cement Company, Orlando, Florida 1976 - 1978 Cornell University, Robert Wood Johnson Graduate School of Management, Ithaca, New York M.P.A. in Health Care Administration 1978 - 1980 University of Florida, Gainsville, Florida Post-Baccalaureate Premed Program (GPA 3.9) 1981 - 1985 Rutgers Medical School, Newark, New Jersey M.D. awarded May, 1985 1985 - 1986 Jersey Shore Medical Center, Neptune, New Jersey Transitional Resident 1986 - 1989 Albany Medical Center Hospital, Albany, New York Resident in Ophthalmology 1989 - 1990 University of Minnesota, Minneapolis, Minnesota Fellowship in Cornea and External Disease, Refractive Surgery, and Small Incision Cataract Surgery (Drs. Lindstrom, & Holland) 1990 - 1992 Corneal Consultants of Ohio, Sylvania, Ohio 1992 - 1998 The Pugliese Eye Specialists, Kingston, PA 1995 - 2000 Adjunct Staff, Wills Eye Hospital, Philadelphia, PA 1998 - Present Founder, Bucci Laser Vision Institute & Ambulatory Surgery Center Wilkes-Barre, PA 2003 - Present Founder, Chairman of the Board, and President, Hospice of the Sacred Heart, Wilkes Barre, PA 2007 - Present Founder and Partner, Instituto de Ojos Sacro Cuore, Miraflores, Lima, Peru 2008 - Present Senior Medical Director for Physician Recommended Nutriceuticals, Plymouth Meeting, PA 1 Scholarships and Awards: Full Four-Year Athletic Scholarship (Basketball) Omicron Delta Kappa Leadership Award Captain 1973-1974 NCAA Eastern Regional Basketball Champions The 1986 Publication Award – Annual Publications Award Competition, Jersey Shore Medical Center Robert D. Reinecke Award 1988 (Outstanding Research by Resident in Ophthalmology) Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO), January, 1990 Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of Contact Lens Association of Ophthalmology (CLAO), January, 1992 Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of Contact Lens Association of Ophthalmology (CLAO), January, 1993 Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO), January, 1994 Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of Contact Lens Association of Ophthalmology (CLAO), January, 1994 Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO), January, 1995 Best Paper of Session - Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2007 Best Poster of Conference - Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2007 American Academy of Ophthalmology’s (AAO) Achievement Award, May, 2007 Speaker of the Day - Royal Hawaiian Eye 2008, Physicians Program, January 21, 2008 The Times Leader Health Care Hero, 2009 Governor Robert P. Casey Medal for a Lifetime of Service 2012 2 Organizations and Licensure: Diplomate, American Board of Ophthalmology Member, American Medical Association Member, American Academy of Ophthalmology/International Society of Refractive Surgery Member, Association for Research and Vision in Ophthalmology Diplomate, National Board of Medical Examiners Ocular Microbiology and Immunology Group Contact Lens Association of Ophthalmology American Society of Cataract and Refractive Surgeons Castroviejo Cornea Society Medical Advisory Board, Northeast PA Lions Eye Bank, Bethlehem, PA Publications: 1. Bucci, F.A., Jr. and Weiner, B.D.: The Pyogenic Granuloma. Arizona Medicine 41:794- 796, 1984. 2. Bucci, F.A., Jr.: Self-Assessment Protocol. Journal American Academy Dermatology 15:26A, 27A, 35A, 1986. 3. Bucci, F.A., Jr., Mesa, M., Schwartz, R.A., McNeil, G., Lambert, W.C.: Oral Lesions in Lepromatous Leprosy. The Journal of Oral Medicine 42:4-6, 1987. 4. Bucci, F.A., Jr., Savia, P.V., Jr., Mauriello, J.A., Jr.: Herpes Zoster Ophthalmicus. American Family Physician 35:121-128, 1987. 5. Bucci, F.A., Jr., Schwartz, R.A.: The Neurologic Complications of Herpes Zoster. American Family Physician 37:185-192, 1988. 6. Bucci, F.A., Jr., Krohel, G.B.: Optic Nerve Swelling Secondary to the Obstructive Sleep Apnea Syndrome. American Journal of Ophthalmology 105:428-430, 1988. 7. Bucci, F.A., Jr.: Oral Leprosy-Self Assessment Protocol, In: Problems in Dermatologic Diagnosis and Management. W. Clark Lambert (Ed.), American Academy of Dermatology, Evanston, Illinois, Pages 10-11, 14-15, 1988. 8. Bucci, F.A., Jr., Gabriels, C.F., Krohel, G.B.: Successful Treatment of Postherpetic Neuralgia with Capsaicin. American Journal of Ophthalmology 106:758, 1988. 3 9. Bucci, F.A., Jr., Catalano, R.A., Simon, J.W.: Discordance of Accommodative Esotropia in Monozygotic Twins. American Journal of Ophthalmology 107:84-85, 1989. 10. Bucci, F.A., Jr., Dimitsopulos, T.M., Krohel, G.B.: Branch Retinal Artery Occlusion Secondary to Percutaneous Transluminal Coronary Angioplasty. British Journal of Ophthalmology 73:221222, 1989. 11. Beyer-Mears, A., Bucci, F.A., Jr., Delnal, M., Cruz, E.: Dietary Myo-Inositol Effect on Sugar Cataractogensis. Pharmacology 39:59-68, 1989. 12. Bucci, F.A., Jr., Holland, E.J.: Flavobacterium Meningosepticum Keratitis Successfully Treated with Topical Trimethoprim-Sulfamethoxazole. American Journal of Ophthalmology 111:116118, 1991. 13. Bucci, F.A., Jr., Lindstrom, R.L.: Total Pupillary Capture with Foldable Posterior Chamber Intraocular Lens. Ophthalmic Surgery 22:414-415, 1991. 14. Bucci, F.A., Jr., Holland, E.J., and Lindstrom, R.L.: Corneal Autografts for External Suture Knots in Transsclerally Sutured Lens Implants. American Journal of Ophthalmology 112:353354, 1991. 15. Bucci, F.A., Jr., Lopatynsky, M.O., Jenkins, P.L., Rickert, D.G., Gold, R.M.: The Acuvue Disposable Contact Lens Versus the CSI Contact Lens in Patients with Giant Papillary Conjunctivitis. American Journal of Ophthalmology 115:454-459, 1993. 16. Chan, C.C., Cogan, D.G., Bucci, F.A., Jr., et.al.: An Anterior Corneal Dystrophy with Dyscollagenosis (Reis-Bucklers type?). Cornea 12:451-460, 1993. 17. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Surevue, Focus, and CSI Daily Wear Lenses in Allergic and Normal Contact Lens Patients. CLAO Journal 20:159166, 1994. 18. Bucci, F.A., Jr., Lopatynsky, M.O., Zloty, P.C.: The Clinical Performance of the Acuvue, NewVues, and SeeQuence Disposable Contact Lenses in Patients with Giant Papillary Conjunctivitis. International Contact Lens Clinics 22:80-86, 1995. 19. Holland, E.J., Lee, R., Bucci, F.A., Jr., et. al.: Mottled Cyan Opacification of the Posterior Cornea in Contact Lens Wearers. American Journal of Ophthalmology 119:620-626, 1995. 20. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Optima Toric Contact Lens Versus the CSI Toric Contact Lens. CLAO Journal 23:43-48, 1997. 21. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: Temporal Correlation of Tear IgE Levels with the Onset of Symptoms in Patients Wearing Contact Lenses. ICLC Journal 22. Bucci, F.A., Jr., Moody, K.J., Tanner, J.B., Klyce, S.: Corneal Topographic Analysis of RingShaped Irregular Astigmatism Caused by Annular Tinted Contact Lenses. CLAO Journal 23:161-167, 1997. 4 23. Bucci, F.A., Jr., Myers, P.J., Tanner, J.B., Moody, K.J., Lopatynsky, M.O.: Clinical and Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the Medalist, Surevue, Biomedics, and Acuvue Lenses. CLAO Journal 23:103-112, 1997. 24. Bucci, F.A., Jr., O’Brien, T.P., Evans, R.E., Myers, P.J.: A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and Ciprofloxacin. Investigative Ophthalmology & Visual Science 41,4:S768, 2000. 25. Bucci, F.A., Jr.: Nutritional Amblyopia Resulting From Intra-Abdominal Surgery for Obesity. (In Preparation) 26. Bucci, F.A., Jr.: An In Vivo Study Comparing the Ocular Absorption of Levofloxacin and Ciprofloxacin Prior to Phacoemulsification. American Journal of Ophthalmology 137:308-312, 2004. 27. Bucci, F.A., Jr.: Consultation Section. Cataract Surgical Problem. Consultation on Management of Case. Journal of Cataract & Refractive Surgery 31,12:2247-2253, 2005. 28. Bucci, F.A., Jr., Waterbury, L., Amico, L.M.: Prostaglandin PGE2 Inhibition and Aqueous Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients Undergoing Phacoemulsification. American Journal of Ophthalmology, 144:147-147, 2007 29. Bucci, F.A., Jr., “In Vivo Pharmacokinetics and In Vitro Pharmacodynamics of Nepafenac, Amfenac, Ketorolac, and Bromfenac”. Journal of Cataract and Refractive Surgery, May 2008. 30. Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing: Aqueous Drug Absorption and PGE2 Levels, Journal of Cataract & Refractive Surgery, August 2008 31. Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing: Aqueous Drug Absorption and PGE2 Levels Aqueous PGE2 at Trough NSAID Levels, Advances in Therapy, March 2009 32. Bucci, F.A., Jr.: Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and Bromfenac Levels After 2 Days Dosing, Advances in Therapy, May 2009 33. Bucci , F. A., Jr.: “A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification, Current Medical Research and Opinion, November 2011. 34. Bucci, F.A., Jr.: “Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Advances in Therapy, November 2011. 35. Bucci, F.A., Jr., Antibacterial Efficacy of Prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology, May 2015. 5 36. Bucci, F.A., Jr., Pharmacokinetics and Aqueous Humor Penetration of levofloxacin 1.5% and moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology, May 2016. 37. Bucci, F.A., Jr., The Effect of Oral Re-Esterified Omega-3 Nutrional Supplementation on Dry Eyes, Cornea, In press. Book Chapters 1. Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Managing Patient Expectations, New Jersey: Slack, Inc., 2008: 360-362. 2. Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Multifocal IOL in One Eye, New Jersey: Slack, Inc., 2008: 454-455. 3. Bucci, FA., Jr.: Mastering Refractive IOLs – The Art and Science, Mini-RK: Indications and Technique, New Jersey: Slack, Inc., 2008: 786-788. 4. Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2012. 5. Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2015. Major Presentations: 1. “Characterization of Mycobacterial Plasmid and Chromosomal DNA.” Presented at the 14th Annual New Jersey Medical School Summer Research Symposium, Newark, New Jersey, Feb. 22, 1982 2. “Myo-Inositol Diminution of Diabetic Cataracts.” Presented at the Annual Spring Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Sarasota, FL, May 7, 1985 3. “Papilledema and Obstructive Sleep Apnea.” Presented at the 9th Annual Albany Ophthalmology Update Albany, New York, May 19, 1987 4. “The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary Conjunctivitis – A Preliminary Report.” Presented at the 10th Annual Albany Ophthalmology Update, Albany, New York, June 18, 1988 5. “The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary Conjunctivitis – A Final Report.” Poster Presentation at the Annual Spring Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Sarasota, FL, May 3, 1989 6. “The Acuvue Disposable Contact Lens and Giant Papillary Conjunctivitis - A 6 Preliminary Report.” Presented at the 11th Annual Albany Ophthalmology Update, Albany, New York, June 3, 1989 7. “The Acuvue Disposable Contact Lens Versus the CSI Lens in Giant Papillary Conjunctivitis – A Final Report.” Poster Presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, Nevada, January 11, 1990 (Awarded Best Scientific Poster) 8. “The Effect of Intraincisional Thrombin on the Rate of Post-Operative Hyphema in Cataract Surgery.” Presented at the Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS), Los Angeles, CA, March 6, 1990 9. “Post-Operative Corneal Swelling in Cataract Patients Using Collagen Shields As a Surgical Adjunct.” Presented at the Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS), Los Angeles, CA, March 6, 1990 10. “Giant Papillary Conjunctivitis.” Presented to the Minnesota Ophthalmological Society (M.O.S.), Minneapolis, MN, June 4, 1990 11. “Giant Papillary Conjunctivitis and Soft Contact Lenses.” Presented at CIBA Vision as a Private Consultant, Atlanta, Georgia, August 9, 1990 12. “Refractive Surgery Update – Four Incision Radial Keratotomy and the Excimer Laser.” Presented to the Northwest Ohio Ophthalmological Society (NOOS), Toledo, OH, March 10, 1991 13. “The Surgical Correction of Myopia.” Presented at the Multidisciplinary Conference of Flower Memorial Hospital, Sylvania, OH, June 11, 1991 14. “Update in Refractive Surgery and the Treatment of Giant Papillary Conjunctivitis.” Presented at the Annual Meeting of the Northeast Pennsylvania Optometry Society, Scranton, PA, May 8, 1992 15. “Corneal Transplantation and Refractive Surgery Updates.” Presented at the Tenth Annual Ophthalmic Assistant Conference of The Pugliese Eye Specialists, Nanticoke, PA, October 10, 1992 16. “The Temporal Correlation of Tear IgE and the Onset of Symptoms in Contact Lens Patients.” Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1993 17. “The Clinical Performance of the Surevue, Focus, and CSI Daily Wear Lenses in Allergic and Normal Contact Lens Patients.” 7 Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1994 (Awarded Best Scientific Poster) 18. “Corneal Topographic Analysis of Ring-Shaped Irregular Astigmatism Caused by Annular Tinted Contact Lenses.” Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1995 (Awarded Best Scientific Poster) 19. “The Clinical Performance of the Optima Toric Contact Lens Versus the CSI Toric Contact Lens.” Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1995 20. “Management of Eightball Hyphema, Iatrogenic Aniridia, and Traumatic Cataract Following Severe Blunt Trauma in a Patient with Previous Mini-RK/AK.” Presented at the International Society of Refractive Surgery (ISRS), Atlanta GA, October, 1995 21. “Case Studies in Refractive and Cataract Surgery.” Presented at the Orange County Ophthalmological Society Meeting, Irvine, CA, December, 1995 22. “Clinical and Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the Medalist, Surevue, Biomedics, and Acuvue Lenses.” Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, February, 1996 23. “Update in Refractive Surgery.” Presented at the Central Pennsylvania Ophthalmology Society Meeting, Camp Hill, PA, March 7, 1996 24. “Advances in Refractive Surgery.” Presented at the Lehigh Valley Ophthalmic Society Meeting, Bethlehem, PA, March 12, 1996 25. “Does Perioperative Topical Marcaine Reduce Symptoms Following Radial Keratotomy? Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS), Minneapolis, MN, July, 1996 26. “Acular Versus Voltaren for the Management of Post-Operative Symptoms Following Radial Keratotomy.” Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS), Minneapolis, MN, July, 1996 27. “Overnight Corneal Swell Response of the Protek Bandage Contact Lens Compared to the 1Day Acuvue, Acuvue, and Proclear Lenses.” Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS), Minneapolis, MN, July, 1996 28. “On-Axis 2-Incision Mini-RK: An Effective Treatment for Primary and Residual Low Myopic Astigmastism.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Chicago, IL, November, 1996 8 29. “The Protek Bandage Contact Lens – Prospective Evaluations of Post-RK Symptom Management and Overnight Corneal Swell Analysis.” Presented at the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, J January, 1997 30. “Comparison of Post-Phacoemulsification IOP in Patients Treated with Timoptic-XE, Iopidine, Trusopt, and Intracameral Carbastat.” Presented at Royal Hawaiian Eye, Maui, HI, January, 1997 31. “Acular Versus Voltaren for the Management of Post-Operative Symptoms Following Radial Keratotomy.” Presented at Royal Hawaiian Eye, Maui, HI, January, 1997 32. “Control of Intraocular Pressure Following YAG Laser – Xalatan vs Alphagan.” Presented at Royal Hawaiian Eye, Maui, HI, January, 1998 33. “A Clinical Comparison of the Acuvue Contact Lens vs the Precision UV Contact Lens.” Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1998 34. “Post-Op Control of Intraocular Pressure Following Phacoemulsification.” Presented at Associazione Italiana di Facoemulsificazione, Rome, Italy, May, 1998 35. “The Role of Non-Steroidal Inflammatory Drops in Laser Vision Correction.” Presented at the 7th Annual Ocular Surgery News Symposium, New York, NY, October, 1998 36. “Control of Post-Op Symptoms Following LASIK – Voltaren vs Acular PF.” Presented at Royal Hawaiian Eye, Kona, HI, January, 1999 37. “A Clinical Comparison of the Precision UV Contact Lens vs the Acuvue Contact Lens with the Orientation Logo and UV Blocker.” Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, January, 1999 38. “Post-Operative Symptom Profiles – PRK vs LASIK.” Presented at Wills Eye Hospital Future Focus Program, Philadelphia, PA, January, 1999 39. “Control of Intraocular Pressure Following YAG Laser Capsulotomy – Iopidine 0.5% vs Alphagan 0.2%.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Seattle, WA, April, 1999 40. “Comparison of Acular PF and Voltaren vs Placebo in the Control of Post-Op Symptoms Following LASIK.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Seattle, WA, April, 1999 41. “Quantitative Analysis of Post-Operative Symptoms – PRK vs LASIK.” 9 Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Seattle, WA, April, 1999 42. “Peri-Operative Medications for Maximizing Patient Satisfaction in LASIK” Presented at the New York State Ophthalmological Society Meeting, New York, NY, September, 1999 43. “NSAIDs and LASIK – What is the Optimum Dose?” Presented at the 8th Annual Ocular Surgery News Symposium, New York, NY, October, 1999 44. “Topical Non-Steroidals and LASIK – What is the Optimum Postop Dose?” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Orlando, Fl, October 1999. 45. “A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and Ciprofloxacin.” Presented at Royal Hawaiian Eye, Maui, HI, January, 2000 46. “The Optimum Use of NSAIDs with LASIK: A Review of Four Prospective Studies.” Presented at Royal Hawaiian Eye, Maui, HI, January, 2000 47. “A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment using Ofloxacin and Ciprofloxacin.” Poster presentation at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March 2000 48. “Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative Inflammation Following Phacoemulsification.” Presented at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March, 2000 49. “A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and Ciprofloxacin.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2000 Annual Meeting, Fort Lauderdale, FL, April, 2000 50. “Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative Inflammation Following Phacoemulsification.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA, May, 2000 51. “A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and Ciprofloxacin.” Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA, May 2000 52. “Rehabilitation of Progressive Hyperopia, Astigmatism and Iatrogenic Aniridia with H LASIK and Astigmatic Keratotomy.” Poster presentation at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Dallas, TX, October 2000 10 53. Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for Myopic LASIK.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Dallas, TX, October, 2000 54. “Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and Refresh Plus Versus TheraTears During the First Month Following LASIK.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Dallas, TX, October, 2000 55. “Optimum Control of Post Phaco Inflammation – Steroids, NSAIDs or Both: The Final Answer.” Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001. 56. “The LASIK Dry Eye: Presentation, Pathophysiology and Treatment.” Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001 57. “Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and Refresh Plus Versus TheraTears During the First Month Following LASIK.” Poster presentation at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March, 2001 58. “Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for Myopic LASIK.” Presented at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March, 2001 59. “Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2001 60. “Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for Myopic LASIK.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2001 61. “Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and Refresh Plus Versus TheraTears During the First Month Following LASIK.” Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2001 62. Rehabilitation of Progressive Hyperopia, Astigmatism, Iatrogenic Aniridia, and Traumatic Cataract with LASIK and AK Following Mini-RK and Severe Blunt Trauma.” Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2001 63. “Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and Refresh Plus Versus TheraTears During the First Month Following LASIK.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting, Fort Lauderdale, FL, April, 2001 64. “Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?” 11 Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting, Fort Lauderdale, FL, April, 2001 65. “The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK?” Poster presentation at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), New Orleans, LA, November, 2001 66. “Myopic Refractive Lensectomy with the Array Multifocal Implant.” Poster presentation at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), New Orleans, LA, November, 2001 67. “Hyperopic Refractive Lensectomy with the Array Multifocal IOL.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), New Orleans, LA, November, 2001 68. “An Objective Comparison of Acular Versus Vexol to Control Inflammation Following Phacoemulsification.” Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology (AAO), New Orleans, LA, November, 2001 69. “The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.” Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology (AAO), New Orleans, LA, November, 2001 70. “The LASIK Dry Eye Update: Tear Lactoferrin, Punctal Plugs, Hinge Position, HydroEye and More.” Presented at Hawaii 2002, Waikoloa, HI, January, 2002 71. An In Vivo Comparison of the Ocular Absorption of Levofloxacin versus Ciprofloxacin Prior to Phacoemulsification.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2002 Annual Meeting, Fort Lauderdale, FL, May, 2002 72. Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.” Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Philadelphia, PA, June, 2002 73. Myopic Refractive Lensectomy with the Array Multifocal Implant.” Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Philadelphia, PA, June, 2002 74. “Effect of HydroEye with Omega Fatty Acids on Tear Lactoferrin.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Philadelphia, PA, June, 2002 75. “Hyperopic Refractive Lensectomy with the Array Multifocal IOL.” Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Philadelphia, PA, June, 2002 76. “Dry Eye In LASIK: Preoperative Evaluation and Prevention.” 12 Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Philadelphia, PA, June, 2002 77. The Role of Fluoroquinolones in the Prevention of Endophthalmitis.” Presented at the 11th Annual Ocular Surgery News Symposium, New York, NY, September, 2002 78. “Myopic Refractive Lensectomy with the Array Multifocal Implant.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), New Orleans, LA, October, 2002 79. “Prevention and Treatment of LASIK Dry Eye Patients.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), New Orleans, LA, October, 2002 80. “Refractive Lensectomy: The Array Multifocal Lens for the Correction of Myopia and Hyperopia”. Presented at Royal Hawaiian Eye, Maui, HI, January, 2003 81. “Myopic and Hyperopic Refractive Lensectomy with the Array Multifocal Implant.” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, April, 2003 82. “The Ocular Absorption of Fluoroquinolone Antibiotics and the Prevention of Endophthalmitis.” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, April, 2003 83. “The Effect of Continuous Preop and Postop Oral Omega Fatty Acids (HydroEye) on Tear Lactoferrin in Bilateral LASIK Patients.” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, April, 2003 84. “The Five Templates of LASIK Dry Eye – The Temporal Assessment and Treatment of Ocular Surface Disease in LASIK Patients.” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, April, 2003 85. “The Effect of Preop Lid Scrubs and Levofloxacin On Eyelid and Conjunctival Cultures Prior To Cataract Surgery.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2003 Annual Meeting, Fort Lauderdale, FL, May, 2003 86. “The Ocular Absorption of Fluoroquinolones and the Prevention of Endophthalmitis.” Presented at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS, Florence Symposium 2003, Florence, Italy, May, 2003 87. “A System for the Diagnosis and Treatment of LASIK Dry Eye.” Presented at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS, Florence Symposium 2003, Florence, Italy, May, 2003 13 88. “Myopic And Hyperopic Refractive Lensectomy with the Array Multifocal Implant.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Munich, Germany, September, 2003 89. “The Effect of Preop Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to Cataract Surgery.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Munich, Germany, September, 2003 90. “Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.” Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery (ISRS), Anaheim, CA, November, 2003 91. “Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to Cataract Surgery.” Presented at The Surgeon’s Fluoroquinolone Symposium, American Academy of Ophthalmology (AAO), Anaheim, CA, November, 2003 92. “Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to Cataract Surgery.” Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004 93. “Long-Term Results of Hyperopic & Myopic Lensectomy with the Array Multifocal Implant.” Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004 94. “A Comparison of Immediate Postop Aqueous Cultures in Phaco Patients Receiving Gatifloxacin and Moxifloxacin Preoperatively.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting, Fort Lauderdale, FL, April, 2004 95. “A Comparison of Conjunctival and Eyelid Cultures in Phaco Patients Receiving Gatifloxacin and Moxifloxacin Preoperatively.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting, Fort Lauderdale, FL, April, 2004 96. “Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to Cataract Surgery.” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, May, 2004 97. “Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, May, 2004 98. “Aqueous, Eyelid and Conjunctival Cultures in Phacoemulsification Using Zymar and Vigamox Preoperatively .” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, May, 2004 14 99. “Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to Cataract Surgery.” Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004 100. “Refractive Lensectomy with the Array Multifocal Implant for Myopes and Hyperopes.” Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004 101. “Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for Myopic LASIK.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Paris, France, September 2004 102. “Long-Term Follow-Up of Refractive Lensectomy With the Array Multifocal Implant in Myopes and Hyperopes.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Paris, France, September 2004 103. “Acular LS Vs Acular in the Control of Inflammation Following Phacoemulsification.” Presented at Royal Hawaiian Eye, Maui, HI, January, 2005 104. “Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for Myopic LASIK .” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Washington, DC, April 2005 105. “Acular, Acular LS, and Voltaren After Phacoemulsification as Mono Therapy and Combined with Pred Forte .” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Washington, DC, April, 2005 106. “Comparison of Ketorolac 0.5%, Ketorolac and Diclofenac 0.1% Combined with Prednisolone 1% on Aqueous Flare Following Cataract Surgery.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2005 Annual Meeting, Fort Lauderdale, FL, May, 2005 107. “Prophylactic Strategies for the Prevention of Endophthalmitis.” Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian Society of Ophthalmology, Florence, Italy, May, 2005 108. “Strategies for the Prevention and Treatment of LASIK Dry Eye.” Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian Society of Ophthalmology, Florence, Italy, May, 2005 109. “Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a Comparison of One Blade Vs. Two Blade Bilateral LASIK.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Lisbon, Portugal, September 2005 15 110. “Intermediate Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS) Conference, Lisbon, Portugal, September 2005 111. “Combining IOLs: Early Results.” Presented at 2nd Annual Refractive IOL Symposium, Las Vegas, NV, December, 2005 112. “Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Presented at Royal Hawaiian Eye, Maui, HI, January, 2006 113. “NSAID Update Acular LS vs. Nevanac.” Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan, Puerto Rico, February, 2006 114. “Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan Puerto Rico, February, 2006 115. “Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a Comparison of One Blade vs. Two Blade Bilateral LASIK.” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, March, 2006 116. “Multifocal IOLs: ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA, March, 2006 117. “Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, April, 2006 118. “Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1% In Patients Undergoing Phacoemulsification.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, April, 2006 119. “A Comparison of Postoperative Inflammation (Flare) Following Routine Phacoemulsification When Using Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1%.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Fort Lauderdale, FL, April, 2006 120. “Prophylactic Strategies for the Prevention of Endophthalmitis.” Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery, Montreal, Canada, April, 2006 121. “Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” 16 Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery, Montreal, Canada, April, 2006 122. “Prophylactic Strategies for the Prevention of Endophthalmitis.” Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and ISRS/AAO, Rome, Italy, May, 2006- 123. “Combining the ReZoom and ReSTOR Multifocal IOLs for Achieving Maximum Patient Outcomes.” Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and ISRS/AAO, Rome, Italy, May, 2006 124. “Presbyopia-Correcting IOLs: Maximizing Patient Satisfaction and Spectacle Independence.” Lecture at the Summer ASCRS Meeting, Boston MA, August, 2006 125. “Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a Comparison of One Blade vs. 2 Blade Bilateral LASIK.” Presented at the XXIV Congress of ESCRS, London, September, 2006 126. “Prophylactic Strategies for the Prevention of Endophthalmitis.” Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006 127. “NSAIDS: Optimizing Surgical Outcomes.” Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN. October, 2006 128. “Multifocal IOLs: Current Perspective.” Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006 129. “Intermediate and Near Visual Function in Bilateral Multifocal Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV, November , 2006 130. “Spotlight on Management of Presbyopia.” Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV, November , 2006 131. “Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.” Presented at the Refractive IOL Symposium, Scottsdale, AZ, December, 2006 132. “ReZoom/ReSTOR vs. ReSTOR/ReSTOR: Patient Satisfaction, Visual Outcomes and Spectacle Independence.” Presented at Royal Hawaiian Eye, Kauai, Hawaii, January, 2007 133. “The Use of NSAIDs with Cataract & Lensectomy Surgery.” Presented at the Ocular Drug & Surgical Therapy Update, Dana Point, CA, February, 2007 134. “Visual Function in Bilateral Lensectomy and Cataract Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR:Long Term Follow-Up.” 17 Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2007 135. “Micro RK/AK to Treat Residual Refractive Errors After Multifocal IOLs vs. Laser Vision Correction and LRI.” Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2007 136. “Comparison of Aqueous Absorption and PGE2 Inhibition with Ketorolac 0.4%, Nepanenec 0.1% and Bromfenac 0.9% in Cataract Patients Treated Preoperatively.” Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA, April, 2007 (Awarded Best Paper of Session) 137. “Aqueous Penetration of Ketorolac 0.4% Compared with Bromfenac 0.9% in Cataract Patients: Peak and Trough Drug Concentration.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting, Fort Lauderdale, FL, April, 2007 138. “Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal Implants.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting, Fort Lauderdale, FL, April, 2007 139. “Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR-Long Term Follow-Up.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting, Fort Lauderdale, FL, April, 2007 140. “Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal Implants.” Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007 - Keynote Address 141. “Near and Intermediate Visual Outcomes in Diffractive/Diffractive vs. Refractive/Diffractive Multifocal Lens Combination.” Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007 142. “The Dynamics of the Preop Presbyopic Consultation.” Presented at the Eye Center Conference, Columbus, OH, September 2007 143. “Mixing Multifocal IOLs to Achieve Maximum Patient Satisfaction.” Presented at the Eye Center Conference, Columbus, OH, September 2007 144. “Treatment Strategies for Residual Refractive Errors and the Results of Unilateral Multifocals.” Presented at the Eye Center Conference, Columbus, OH, September 2007 145. “Vaseline Vision Dysphotopsia” and Explantation of the ReSTOR and ReZoom Multifocal Implants.” 18 Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 200 146. “Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic IOLs.” Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 2007 147. “Unilateral Implantation of the ReZoom and ReSTOR Multifocal IOLs” Presented at the American Academy of Ophthalmology, New Orleans, LA, November 2007 148. “ “Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic IOLs”, Poster Presentation American Academy of Ophthalmology, New Orleans, LA, November 2007 149. “Achieving Success with Multifocal IOLs: Clinical Results and Practical Pearls”, Course Senior Instructor, American Academy of Ophthalmology, New Orleans, LA, November 2007 150. “Maximizing Patient Satisfaction with Presbyopia Correcting IOLs”, Presented at Sunday Breakfast Seminar, Royal Hawaiian Eye, Waikoloa, HA, January 2008 151. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Royal Hawaiian Eye, Waikoloa, HA, January 2008 152. “First 100 Days”, Hawaiian Eye – Subspecialty Saturday, Royal Hawaiian Eye, Waikoloa, HA, January 2008 153. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Nursing and Allied Health Program, Royal Hawaiian Eye, Waikoloa, HA, January 2008 154. “Staying in Step with Innovation”, Course presented at SECO International, February 2008 155. “When to Explant”, Presentation at 2008 Winter Cataract Refractive Invitational Summit, Telluride, CO, February 2008 156. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Presentation at Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada, February 2008 157. “Multifocal IOL Selection for Achieving Patient Satisfaction”, Presentation at Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada, February 2008 158. “Vaseline Vision Dysphotopsia/Treating Residual Refractive Error”, Presentation at Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada, February 2008 159 “The TECNIS Multifocal”, Presentation at the Aspen Invitational Refractive Symposium, Aspen, CO, March 2008 160. “Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating IOLS”, Presented at Ground Rounds Downstate Medical Center, New York, 19 March 2008 161. “Conjunctival Goblet Cell Density Following Sequential Therapy with Artificial Tear and Cyclosporine 0.05%”, Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Chicago, IL, April 2008 162. “Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating IOLs”, Presented as course at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Chicago, IL, April 2008 163. “The 10 P’s of Correcting Presbyopia: Pearls for Maximizing Patient Satisfaction” Presented at The IV International Congress of Refractive Surgery, Cataract and Glaucoma, Lima, Peru, April 2008 164. “Optimizing the Use of PCIOLs: Unilateral, Bilateral, Mix & Match” Presented The IV International Congress of Refractive Surgery, Cataract and Glaucoma, Lima, Peru, April 2008 165. “A Comparison of Silcone Hydrogel vs. Specialty Dry Eye Contact Lenses in Previous Dry Eye Patients with and without Restasis”, Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2008 Annual Meeting, Fort Lauderdale, FL, May 2008 166. “Visual Outcomes and Patient Satisfaction of Cataract and Refractive Lensectomy Patients Receiving Bilateral ReZoom Multifocal Implants”, Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2008 Annual Meeting, Fort Lauderdale, FL, May 2008 167. “NSAIDs in Today’s Ophthalmology Climate”, Allergan External Disease Market Guidance Program, Boston, MA- May 2008 168. “Endophthalmitis Prevention”, Allergan External Disease Market Guidance Program, Boston, MA- May 2008 169. “Optimizing Outcomes in Refractive Surgery”, Allergan External Disease Market Guidance Program, Boston, MA- May 2008 170. “Alternatives for Correcting Residual Refractive Errors: Laser & Incisional”, New York SOURCE Symposium, New York, NY – June 2008 171. “Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and Bromfenac Levels After 2 Days Dosing” Presented at: ARVO Summer Eye Research Conference (SERC), Monterey, CA – July 2008 172. “Update on the Tecnis Multifocal IOL”, Summer Refractive Invitational Summit 2008, Aspen, CO – July 2008 173. “Unilateral Implantation of the ReZoom & ReSTOR Multifocal IOLs”, Presented at the XXVI Congress of ESCRS, Berlin, Germany – September 2008 20 174. “Tailoring the Presbyopic Consultation & Strategied for Achieving an Effective Preoperative Interview”, Refractive IOL Symposium, Las Vegas, NV – September 2008 175. “NSAIDs & Anti-Infectives Panel”, Corneal Health Roundtable, Ocular Surgery News Symposium, New York, NY – October 2008 176. “Achieving Success with Presbyopic Correcting IOLs”, The Montreal Eye Clinic’s 9th Optometric Symposium, Montreal, Quebec – October 2008 177. “Implantation of Presbyopic Correcting IOLs Post Keratorefractive Surgery in Cataract and Lensectomy Patients”, American Academy of Ophthalmology, Atlanta, GA – October 2008 178. “Roadmap to Success with Multifocal IOLs”, Meeting Instruction Course, American Academy of Ophthalmology, Atlanta, GA – October 2008 179. “10 Pearls to Improve Outcomes with Advance Multifocal IOL Implantation”, American Academy of Ophthalmology, Atlanta, GA – October 2008 180. “Surgical Treatment of Presbyopia”, Focal Points: Clinical Modules for Ophthalmologists, American Academy of Ophthalmology, Atlanta, GA – October 2008 181. “Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”, Royal Hawaiian Eye, Maui, HA – January 2009 182. “Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”, Nursing and Allied Health Program, Royal Hawaiian Eye , Maui, HA – January 2009 183. Allergan Dry Eye Advisory Summit, Miami Beach, FL – February 2009 184. “Unilateral Implantation of Presbyopic Correcting IOLs: Comparison of ReZoom, ReSTOR, Cyrstalens 5.0, and Crystalens HD”, Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, 2009 Annual Meeting, San Francisco - April 2009 185. “Maximizing Patient Satisfaction with Presbyopic Correcting IOLs”, Course Instructor JCAHPO/ASCRS Technicians & Nurses Program, ASCRS 2009 Annual Meeting, San Francisco, CA - April 2009 186. “Ten Pearls to Improve Outcomes with Advanced Multifocal IOL Implantation”, Co-Instructor Course Instructor, ASCRS 2009 Annual Meeting, San Francisco, CA April 2009 187. “Bioavailability of Ethyl Ester Versus Triglyceride Omerga-3 Fatty Acids”, Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco, CA - April 2009 188. “Pharmacokinetics and Aqueous Humor Penetration”, Presented at Vistakon Pharmaceuticals ASCRS Breakfast Symposia, ASCRS, San Francisco, CA - April 2009 21 189. “The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, ARVO, May 2009 190. “Achieving Clinical Success with the New TECNIS Multifocal”, Ocular Surgery News New York, NY – September 2009 191. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Ocular Surgery News New York, NY – September 2009 192. “Do YAG Capsulotomies in Eyes with a Crystalens Significantly Impact Spherical Refraction and Near Visual Function?”, ISRS/AAO Refractive Surgery Subspecialty Day, San Francisco, CA – October 2009 193. “A Novel Pharmacokinetic Study Comparing Corneal Penetration of Levofloxacin 1.5% and Moxifloxacin 0.5%”, New Insights into Corneal Protection, American Academy of Ophthalmology, San Francisco, CA – October 2009 194. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor, Roadmap to Success with Presbyopic IOLs, American Academy of Ophthalmology, San Francisco, CA – October 2009 195. “Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective Preoperative Interview”, Co-Instructor, American Academy of Ophthalmology, San Francisco, CA – October 2009 196. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor Presbyopia Correcting IOL’s: The Best Option, American Academy of Ophthalmology, San Francisco, CA – October 2009 197. “Mixing and Matching Presbyopia-Correcting IOLs”, Online course for the American Academy of Ophthalmology O.N.E. program, San Francisco, CA – October 2009 198. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”, Moderator Roundtable, Philadelphia, PA – November 2009 199. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”, Moderator Roundtable, New York, NY – November 2009 200. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration, Defocus, and Pupil Size on Near Visual Performances of Models of Blended Hinged Accommodating IOLS", Nursing and Allied Health Program, Royal Hawaiian Eye , Koloa, HA – January 2010 201. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration, Defocus, and Pupil Size on Near Visual Performances of Models of Blended Hinged Accommodating IOLS", Royal Hawaiian Eye , Koloa, HA – January 2010 202. "The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and Moxifloxacin 05% in Patients Undergoing Cataract Surgery", The 5th International Conference on Ocular Infections, Palm Beach, FL - February, 2010 22 203. "Achieving Success with Presbyopic Correcting IOLs: Preoperative Counseling, IOL Selection, and Treatment of Residual Refractive Error, Course Instructor, American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA - April 2010 204. "Effect of Postoperative Atropine, YAG Capsulotomy, Spherical Aberration, Defocus, and Pupil Size on Near Visual Performances of Two Models of Blended Aspheric Hinged Accommodating IOLs, Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA - April 2010 205. "Comparison of Staged Implantation Strategies with Multifocal and Accomodating IOLs for Maximizing Patient Satisfaction, Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA - April 2010 206. "Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification", Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2010 Annual Meeting, Fort Lauderdale, FL, May 2010 207. "Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2010 Annual Meeting, Fort Lauderdale, FL, May 2010 208. " Visual Performance and Patient Satisfaction When Mixing a TECNIS Multifocal with a Crystalens", Presented at the XXVIII Congress of ESCRS, Paris, France – September 2010 209. " Bilateral Visual Outcomes with the Combination of a Crystalens and TECNIS Multifocal", E-Poster, ISRS/AAO Refractive Surgery Subspecialty Day, Chicago, IL October 2010 210. "Visual Performance and Patient Satisfaction When Mixing a Diffractive Multifocal IOL with an Accommodating IOL", Royal Hawaiian Eye , Maui, HA – January 2011 211. "Comparison of RBC Saturation withOmega-3 Oral Supplements", Electronic Poster, Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA - March, 2011 212. " Ketorolac vs. Bromfenac: A Review of 7 Prospective Randomized Studies Comparing PGE2 Inhibition and Aqueous Penetration", Electronic Poster Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA March, 2011 213. "A Comparison of Omega-3 RBC Saturation for Three Oral Supplements: Dry Eye Omega Benefits vs. TheraTears Nutrition vs. Nature Made, Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2011 Annual Meeting, Fort Lauderdale, FL, May 2011. 23 214. " A Comparison of the Bioavailability by Red Blood Cell Saturation of Re-esterified Triglyceride Omega-3s vs. Ethyl Ester Omega-3s presented as an ePoster at the American Academy of Ophthalmology, Orlando, FL, October 2011. 215. "The Art of Achieving Success With Presbyopic-Correcting Intraocular Implants: The Consultation, the IOLs, and Correcting Residual Refractive Errors, Course Instructor, American Academy of Ophthalmology, Orlando, FL, October 2011. 216. "Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective Preoperative Interview", Royal Hawaiian Eye , HA – January 2012. 217. "An Outcomes Comparison of Bilateral vs. Mix & Match: What I have learned after implanting 2600 Presbyopic Correcting IOLs ", HA - January 2012. 218. "A Comparison of Bilateral Diffractive Multifocal to a Diffractive Multifocal Combined with a Zonal-Refractive Multifocal IOL", American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Chicago 2012. 219. "A Comparison of the Bioavailability by RBC Saturation of Re-esterified Triglyceride Omega-3s vs. Ethyl Ester Omega-3s", American Society of Cataract and Refractive Surgery (ASCRS) Symposium, Chicago 2012. 220. "Visual Performance, Reading Speed, and Patient Satisfaction after Receiving Bilateral Multifocal IOLs", American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Francisco 2013. 221. "The Pharmacokinetics and Aqueous Humor Penetration of Besifloxacin 0.6% and Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery", Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Annual Meeting, Seattle 2013. 222. "A Comparison of Prophylactic Antibacterial Efficacy of Besifloxacin 0.6% versus Moxifloxacin 0.5% at 1 hour and 3 days prior to Phacoemulsification", Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), 2013 Annual Meeting, Seattle 2013. 223. “Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye , HA, January 2014. 224. “Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data of Patients Receiving Diffractive Multifocal Implants”, Nursing and Allied Health Program, Royal Hawaiian Eye , HA – January 2014. 225. “Antibacterial Susceptibility of Coagulase Negative Staph Before and After Prophylactic Use of Besifloxacin and Moxifloxacin”, Poster presentation at Association for Research in Vision and Ophthalmology Annual Meeting, Orlando (ARVO), 2014. 226. “Multivariate Regression Analysis of Overall Bilateral Patient Satisfaction in Patients Receiving Bilateral TECNIS Multifocal Implants”, European Society of Cataract and 24 Refractive Surgeons Annual Meeting (ESCRS), London, 2014. 227. “Multivariate Analysis of Overall Bilateral Satisfaction vs Preoperative and Outcome Data of Patients Receiving Diffractive Multifocal Implants”, Electronic poster presentation, International Society of Refractive Surgery Annual Meeting (ISRS), Chicago 2014. 228. “Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye, HA, January 2015. 229. “Effect of Oral Re-esterified Omega-3 Supplementation on Dry Eye Disease: Double-masked Randomized, Multicenter, and Placebo-controlled Study”, Royal Hawaiian Eye, HA, January 2016. 230. “A Comparison of the Frequency of Use of the Malyugin Ring® With and Without Intracameral Phenylephrine & Ketorolac 1%/0.3% Injection at the Time of Routine Cataract Surgery”, ARVO, Seattle, WA, May 2, 2016. 231. “The Effect of Mesopic Pupil Size and IOL Centration on Overall Patient Satisfaction with the TECNIS Multifocal IOL”, ASCRS, New Orleans, 2016. 232. “Achieving Success with Presbyopic Correcting IOLs: Pre op Counseling, IOL Selection, and Treatment of Residual Refractive Error”, Course Instructor, ASCRS, New Orleans, 2016. Trade Periodical “Publications” 1. Bucci, F.A., Jr.: Roundtable Participant. “Maximizing Success in Refractive Surgery”. Ocular Surgery News. June 1997. 2. Bucci, F.A., Jr.: Roundtable Participant. “Management of Ocular Inflammation: Evaluating Current Treatment Options”. Ocular Surgery News. July 1997. 3. Bucci, F.A., Jr.: Roundtable Participant. “Opportunities and Techniques in Improving Cataract Patient Outcomes”. Ocular Surgery News Supplement. May 1999. 4. Bucci, F.A., Jr.: Roundtable Participant. “Ocular Surface Rehabilitation”. CIBA Vision Ophthalmics by The Willow Group, Inc. August 1999. 5. Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology Times. February 2000. 6. Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Immediately Following LASIK is the Best Regimen”. Ocular Surgery News. April 2000. 7. Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Helps Post-LASIK Relief”. Ophthalmology Times. May 2000. 8. Bucci, F.A., Jr.: Research Featured In: “Surgeons Extrapolate the Best Prophylaxis Methods from Studies”. Ocular Surgery News. July 2000. 25 9. Bucci, F.A., Jr.: Research Featured In: “Post Cataract Combination Therapy”. EyeWorld. May 2001. 10. Bucci, F.A., Jr.: Research Featured In: “Head Off Dry Eye Before Surgery - 10 Questions You Must Ask Your LASIK Patients”. Optometric Management. May 2001. 11. Bucci, F.A., Jr.: Research Featured In: “Nonsteroidal Anti-Inflammatory Drugs: Options and Applications in Ophthalmic Use”. Ocular Surgery News. May 2001. 12. Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”. Ocular Surgery News. September 2001. 13. Bucci, F.A., Jr.: Research Featured In: “A Review of the ASCRS NSAIDs Survey Results”. EyeWorld. September 2001. 14. Bucci, F.A., Jr.: Research Featured In: “Plugs Benefit High-Risk Cases”. Ophthalmology Times. August 2001. 15. Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”. Ocular Surgery News. August 2001. 16. Bucci, F.A., Jr.: Research Featured In: “Perioperative Prophylaxis – The Search for the Surgeon’s Fluoroquinolone”. EyeWorld. November 2001. 17. Bucci, F.A., Jr.: Research Featured In: “Dry Eye Treatment Can Elevate Lactoferrin Levels in Tears Prior to Refractive Surgery”. Ocular Surgery News. February 2002. 18. Bucci, F.A., Jr.: Research Featured In: “Update On Diagnosing Dry Eye”. Ophthalmology Management. February 2002. 19. Bucci, F.A., Jr.: Research Featured In: “Post-LASIK Dry Eye Can Be Managed Effectively Surgeons Say”. Ocular Surgery News Europe/Asia-Pacific Edition. March 2002. 20. Bucci, F.A., Jr.: Research Featured In: “At Issue Column-Management of LASIK Dry Eye”. Ocular Surgery News. March 2002. 21. Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology Times. April 2002. 22. Bucci, F.A., Jr.: Research Featured In: “Surgeon: Punctal Plugs Help Restore Tear Lactoferrin”. Ocular Surgery News. April 2002. 23. Bucci, F.A., Jr.: “Astigmatism, High Myopia, and the Array”. Cataract & Refractive Surgery Today. April 2002. 24. Bucci, F.A., Jr.: “Endophthalmitis Prophylaxis and the Corneal Penetration of Topical Fluoroquinolones”. Cataract & Refractive Surgery Today. April 2002. 26 25. Bucci, F.A., Jr.: Research Featured In: “Complications of Refractive Surgery”. EyeWorld. July 2002. 26. Bucci, F.A., Jr.: Research Featured In: “Dealing with Dry Eye”. EyeWorld. June 2002. 27. Bucci, F.A., Jr.: Co-author of Monograph: “Ophthalmic Therapeutics: The Surgeon’s Fluoroquinolone”. Ocular Surgery News. May 2002. 28. Bucci, F.A., Jr.: Co-author of Monograph: “Treating Ocular Surface Disease Through Medical Therapy”. Ophthalmology Times. September 2002. 29. Bucci, F.A., Jr.: Research Featured In: “Lensectomy with Multifocal IOL Renders Impressive Visual Results”. Ocular Surgery News. November 2002. 30. Bucci, F.A., Jr.: Research Featured In: “Preventing Postoperative Infection”. Cataract & Refractive Surgery Today. November 2003. 31. Bucci, F.A., Jr.: Co-author of Monograph: “The Surgeon’s Fluoroquinolone: Letting the Science Speak for Itself”. Ocular Surgery News. November 2003. 32. Bucci, F.A., Jr.: Research Featured In: “Omega Fatty Acid Supplements Useful Strategy Before LASIK”. Ophthalmology Times. November 2003. 33. Bucci, F.A., Jr.: Research Featured In: “A Dry Eye Regimen for Cold Weather?”. EyeWorld. November 2003. 34. Bucci, F.A., Jr.: Research Featured In: “Lid Scrubs Plus Levofloxacin a Potent Antimicrobial Prophylaxis”. ESCRS Eurotimes. November 2003. 35. Bucci, F.A., Jr.: Research Featured In: “Comprehensive Dry Eye Treatments”. Cataract & Refractive Surgery Today. January 2004. 36. Bucci, F.A., Jr.: Research Featured In: “Treating the Dry Eye: The Role of Artificial Tears”. Refractive Eyecare For Ophthalmologists. June 2004. 37. Bucci, F.A., Jr.: Research Featured In: “NSAIDs Steroids, or Both for Cataract Surgery?”. EyeWorld. August 2004. 38. Bucci, F.A., Jr.: Research Featured In: “Easing Surgical Recovery”. Ophthalmology Management. September 2004. 39. Bucci, F.A., Jr.: Research Featured In: “Options to Consider for Bed Hydration”. EyeWorld. September 2004. 40. Bucci, F.A., Jr.: Research Featured In: “Topical Antibiotic Prophylaxis”. Cataract & Refractive Surgery Today. February 2005. 41. Bucci, F.A., Jr.: Roundtable Participant. “NSAID Uses in Cataract and Refractive Surgery”. Supplement to Ophthalmology Times. February 2005. 27 42. Bucci, F.A., Jr.: Research Featured In: “A Strategy for Endophthalmitis Prophylaxis”. Refractive Eyecare. November 2005. 43. Bucci, F.A., Jr.: Cataract Surgery Phaco Pearls Participant. “Achieving a Watertight Incision”. Cataract & Refractive Surgery Today. January 2006. 44. Bucci, F.A., Jr.: Roundtable Participant. “Philosophy of Mixing IOLs for Presbyopia Correction Spurs Debate”. Ocular Surgery News. January 2006. 45. Bucci, F.A., Jr.: Roundtable Participant. “LASIK Infection Prophylaxis: A Roundtable Discussion”. Review of Ophthalmology. February 2006. 46. Bucci, F.A., Jr.: Featured In: “Highlights of ASCRS”. Ocular Surgery News. April 2006 47. Bucci, F.A., Jr.: Featured In: Mixing & Matching vs. Bilateral IOLs”. Refractive Surgery Quarterly. 2006. 48. Bucci, F.A., Jr.: Featured In: “ASCRS Summer Refractive Congress Highlights New Technologies”. Ocular Surgery News. September 2006. 49. Bucci, F.A., Jr.: Featured In: “Patient Selection, Preoperative Evaluation Critical for Success”. Ocular Surgery News Supplement. October 2006. 50. Bucci, F.A., Jr.: Featured In: “Flap Thickness Formula Aids in Decision-Making”. Ophthalmology Times. January 2007. 51. Bucci, F.A., Jr.: Research Featured In: “Mixing & Matching IOLs”. Cataract & Refractive Surgery Today Supplement. February 2007. 52. Bucci, F.A., Jr.: Roundtable Participant. “IOL Options in 2007”. Cataract & Refractive Surgery Today – Annual IOL Issue. February 2007. 53. Bucci, F.A., Jr.: Waxy Vision and Selected Multifocal IOL; Managing Patient Expectations, Ocular Surgery News, March 2007 54. Bucci, F.A., Jr.: Research Featured In: “Studies Suggest Superiority of Ketorolac in Cataract Surgery”. Special Section: ASCRS Cataract News – Ophthalmology Times July 2007. 55. Chu, Y.R., Bucci, F.A., Jr., McDonald II, J.E., et. al.: “Refractive Lens Exchange”. Cataract & Refractive Surgery Today. August 2007. 56. Bucci, F.A., Jr.: Research Featured In: Endophthalmitis Should Not Overshadow Other Severe Complications”. Ocular Surgery News. October 2007. 57. Bucci, F.A., Jr.: “Mastering Preoperative Interviews”. Cataract & Refractive Surgery Today. November/December 2007. 58. Bucci, F.A., Jr.: “Roudtable Participant. “Attracting, Communicating, and Converting Patients to Refractive IOLs”. Cataract & Refractive Surgery Today. November/December 2007. 28 59. Bucci, F.A., Jr.: “Mixing and Matching with the ReZoom Multifocal: Best of Both Worlds?”. EyeWorld. May / June 2008. 60. Bucci, F.A., Jr.: A Multifocal with Mass Appeal: The Tecnis Multifocal IOL, Cataract & Refractive Surgery Today, January 2009. 61. Bucci, F.A., Jr.: Natural Triglycerides Omega-3s Out Perform Ethyl Ester Omegas, Optimizes Dry Eye Treatment and ARMD Prevention, Ocular Surgery News, June 2009. 62. Bucci, F. A., Jr., Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and Bromfenac Levels After 2 days Dosing, Advances in Therapy, June 2009. 63. Bucci, F.A., Jr., Corneal Aqueous Penetration: Fluoroquinoline Pharmacokinetic Study Findings, ASCRS EyeWorld, August 2009. 64. Bucci, F.A., Jr., Clinician's Corner, Focal Points, Clinical Modules for Ophthalmologists, September, 2009. 65. Bucci, F.A., Jr., Building a Presbyopic IOL Practice, Practice Management, Special to Ophthalmology Times, October 2009. 66. Bucci, F.A., Jr., Update on Mastering Refractive IOLs: Tools of the Trade, Premier Surgeon, July/August 2010. 67. Bucci, F.A., Jr., Methicillin Resistance of Staphylococcus Species Among Health Care and Nonhealth Care Workers Undergoing Cataract Surgery, Clinical Ophthalmology, December 2010. 68. Bucci, F.A., Jr., Four Errors in Prescribing Antibiotics, Cataract and Refractive Surgery Today, February 2011. 69. Bucci, F.A., Jr., Omega-3 and Dry Eye: Looking at Science and Clinical Experience, EyeWorld, October, 2012. 70. Bucci, F.A., Jr., Talking NSAIDs for Phacoemulsification, EyeWorld, October, 2012. 71. Bucci, F.A., Jr., The Differences in My Phaco Technique With Laser Cataract Surgery, Cataract and Refractive Surgery Today Europe, October 2012. 72. Bucci, FA, Jr., Upside Down Multifocal IOL, Cataract and Refractive Surgery Today, January 2013. 29